Duke logo

SIMT Stereotactic Radiosurgery Outcomes Study (Brain Cancers) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to understand the side effects of treatment and effect on mental functioning in patients that are treated with SRS.

What is the Condition Being Studied?

Brain Cancer

Who Can Participate in the Study?

Adults who:
- Are diagnosed with 4 -10 brain tumors, each of which measures less than 4cm.
- Have had surgery to remove the brain tumors
- Are able to complete MRI imaging

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Be asked to complete mental function assessments and quality of life questionnaires before radiation treatment and at all follow up visits.
- Have a Magnetic resonance imaging (MRI) and Computed Tomography (CT) scans to plan for your radiation dose and delivery.
- Be given Radiation treatment in 1-5 treatments
- Be involved for about 2 years

Study Details

Full Title
Outcome in Patients with 4 or more Brain Metastases Treated with Single-Isocenter, Multi-Target (SIMT) Stereotactic Radiosurgery: A Prospective Single-Arm Study in Adults with Brain Metastases
Principal Investigator
Radiation Oncologist
Protocol Number
IRB:PRO00075429
NCT:NCT02886572
Phase
Phase II
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698